Brandes Reports 14.12% Stake in Utah Medical

Accepted by SEC EDGAR 05/14/2026 - 05:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Brandes Investment Partners amended a Schedule 13G to report beneficial ownership in Utah Medical Products, Inc. The filing states Brandes beneficially owns 449,680 shares, representing 14.12% of the class, with 412,007 shares reflecting shared voting power.

The disclosure lists CUSIP 917488108 and the reporting person as Brandes Investment Partners, L.P. The amendment is signed by Glenn Carlson as Executive Director.

Insights

Institutional Ownership Analyst

Brandes holds a sizeable disclosed stake of 14.12% in UTMD.

Brandes Investment Partners reports beneficial ownership of 449,680 shares with 412,007 shares of shared voting power. This filing is a routine beneficial-ownership disclosure required for large passive holders.

Subsequent filings may show changes; timing and cash-flow treatment are not part of this excerpt.

Key Figures

Beneficial ownership: 449,680 shares Percent of class: 14.12% Shared voting power: 412,007 shares +2 more

5 metrics

Beneficial ownership 449,680 shares Amount beneficially owned (Schedule 13G/A)

Percent of class 14.12% Percent of class as reported

Shared voting power 412,007 shares Shared power to vote or to direct the vote

Shared dispositive power 449,680 shares Shared power to dispose or to direct disposition

CUSIP 917488108 Security identifier for Common Shares

Key Terms

Schedule 13G/A, Beneficial ownership, Shared voting power, Dispositive power

4 terms

Schedule 13G/A regulatory

"Amendment No. 3 ) UT AH MEDICAL PRODUCTS INC Common Shares"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership regulatory

"Item 4. | Ownership (a) | Amount beneficially owned: 449,680"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Shared voting power regulatory

"Shared power to vote or to direct the vote: 412,007"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

Dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 449,680"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Brandes report in UTMD?

Brandes reports beneficial ownership of 449,680 shares, representing 14.12% of Utah Medical Products. The filing shows 412,007 shares where Brandes has shared voting power, per the Schedule 13G/A amendment.

Is Brandes the filing person for UTMD Schedule 13G/A?

Yes. The filing names Brandes Investment Partners, L.P. as the reporting person and lists its address in La Jolla, California. The amendment is signed by Glenn Carlson as Executive Director.

Does the Schedule 13G/A show sole voting or dispositive power?

No. The filing reports 0 shares of sole voting power and 0 sole dispositive power; voting and dispositive authority are shown as shared for the disclosed shares.

What identifying details appear in the UTMD filing?

The amendment includes CUSIP 917488108, issuer address in Midvale, Utah, and the reporting person’s business address at 4275 Executive Square, La Jolla, CA, per the Schedule 13G/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

UTAH MEDICAL PRODUCTS INC

(Name of Issuer)

Common Shares

(Title of Class of Securities)

917488108

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 917488108

1

Names of Reporting Persons

BRANDES INVESTMENT PARTNERS, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 412,007.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 449,680.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

449,680.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

14.1 %

12

Type of Reporting Person (See Instructions)

IA, PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UTAH MEDICAL PRODUCTS INC
(b)	Address of issuer's principal executive offices: 7043 S 300 WEST, MIDVALE, UTAH, 84047.
Item 2.
(a)	Name of person filing: Brandes Investment Partners, L.P.
(b)	Address or principal business office or, if none, residence: 4275 Executive Square, 5th Floor, La Jolla, CA 92037
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: 917488108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 449,680
(b)	Percent of class: 14.12 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 412,007
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 449,680
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BRANDES INVESTMENT PARTNERS, LP

Signature:	/s/ Glenn Carlson
Name/Title:	Executive Director
Date:	05/07/2026